TOKYO, December 16, 2020 --- FUJIFILM Corporation (President: Kenji Sukeno) is pleased to announce that it has achieved a world record 317 Gbpsi recording density with data storage tapes using a new magnetic particle called Strontium Ferrite (SrFe)4. The record was set in tests conducted jointly with IBM Research. These tests signal the development of […]
Fujifilm and Caringo Seamlessly Integrate Disk and Tape-Based Object Storage Solutions
Complete, on-premises S3 object storage solution for active access to cold archive data offers optimal price/performance and security for multi-petabyte environments Valhalla, NY and Austin, TX, November 17, 2020 — FUJIFILM Recording Media U.S.A., Inc. and Caringo, Inc. announced today a joint marketing partnership to offer a complete, on-premises data management solution for multi-petabyte environments […]
Integrated storage solution enables users to combine the benefits of tape and modern S3-compatible object storage ecosystem with FUJIFILM OBJECT ARCHIVE software Valhalla, N.Y. – FUJIFILM Recording Media U.S.A., Inc. (President & CEO: Peter Faulhaber) today announced a joint marketing partnership with Cloudian® that brings the performance benefits and search capabilities of Cloudian’s fully native, S3-compatible […]
FUJIFILM Recording Media U.S.A., Inc. today announced a unique subscription pricing model for their FUJIFILM Object Archive solution. The S3 compatible gateway to tape software solution makes hybrid cloud storage, cold data archiving and increased data security environments a reality. In addition, the new subscription model provides a low cost of ownership and can be […]
Fujifilm accelerates production of its influenza antiviral drug “Avigan® Tablet” for COVID-19
FUJIFILM Corporation (President: Kenji Sukeno) has announced that it has expanded its manufacturing capacity at FUJIFILM Toyama Chemical Co., Ltd. to significantly increase production of its influenza antiviral drug “Avigan® Tablet” (generic name: favipiravir) for treating patients with COVID-19. To further boost the supply of Avigan, Fujifilm is allocating additional capacity at its FUJIFILM Wako Pure Chemical Co., Ltd. facility in Japan, for production of pharmaceutical intermediates used to manufacture Avigan. In […]
FUJIFILM Corporation (President: Kenji Sukeno) announces the initiation of a U.S. phase II clinical trial to evaluate the safety and efficacy of its influenza antiviral drug “Avigan® Tablet” (generic name: favipiravir) for patients with COVID-19, a respiratory infection caused by the novel SARS-CoV-2 coronavirus. Avigan, approved in Japan for manufacture and sale as an influenza antiviral drug, […]
FUJIFILM Toyama Chemical Co., Ltd. (President: Junji Okada) has announced today the initiation of a phase III clinical trial to evaluate the safety and efficacy of influenza antiviral drug “Avigan Tablet” (generic name: favipiravir) in Japan for patients of COVID-19, a respiratory infection caused by the novel Coronavirus (SARS-CoV-2). Following the rapid and global outbreak […]
FUJIFILM Toyama Chemical Co., Ltd. (President: Junji Okada) has announced today the initiation of a phase III clinical trial to evaluate the safety and efficacy of influenza antiviral drug “Avigan Tablet” (generic name: favipiravir) in Japan for patients of COVID-19, a respiratory infection caused by the novel coronavirus (SARS-CoV-2). Following the rapid and global outbreak […]
Covid-19 Update from Peter Faulhaber, Fujifilm Recording Media U.S.A. President and CEO
To Our Valued Customers: First and foremost, I trust that you and your family are well during this unprecedented pandemic. On March 23, 2020, Charles D. Baker, the Governor of the Commonwealth of Massachusetts, issued COVID-19 Executive Order No. 13. The Executive Order requires all businesses and organizations that do not provide “Essential Services” to […]
We can help you reduce cost, decrease vendor lock-in, and increase productivity of storage staff while ensuring accessibility and longevity of data.
Contact Us >|
|